about
Antibody and cytokine-associated immune responses to S. equi antigens entrapped in PLA nanospheres.New thermoresistant polymorph from CO2 recrystallization of minocycline hydrochloride.Exploring a new jellyfish collagen in the production of microparticles for protein delivery.Effect of Experimental Parameters on Alginate/Chitosan Microparticles for BCG Encapsulation.Advanced systems for glucocorticoids' dermal delivery.Nanostructured lipid carriers: Promising drug delivery systems for future clinics.Nanoparticulate platforms for targeting bone infections: meeting a major therapeutic challenge.Toxicity screening of a novel poly(methylmethacrylate)-Eudragit nanocarrier on L929 fibroblasts.A Quality by design (QbD) approach on starch-based nanocapsules: A promising platform for topical drug delivery.Development of solid lipid nanoparticles as carriers for improving oral bioavailability of glibenclamide.Rifabutin-loaded solid lipid nanoparticles for inhaled antitubercular therapy: Physicochemical and in vitro studies.Pickering emulsions: challenges and opportunities in topical delivery.Generation of an antibody that recognizes Plasmodium chabaudi cysteine protease (chabaupain-1) in both sexual and asexual parasite life cycle and evaluation of chabaupain-1 vaccine potential.Key-properties outlook of a levofloxacin-loaded acrylic bone cement with improved antibiotic delivery.Improvement of the antibacterial activity of daptomycin-loaded polymeric microparticles by Eudragit RL 100: an assessment by isothermal microcalorimetry.A novel modified acrylic bone cement matrix. A step forward on antibiotic delivery against multiresistant bacteria responsible for prosthetic joint infections.Co-encapsulating nanostructured lipid carriers for transdermal application: from experimental design to the molecular detail.Preclinical evaluation of a pulmonary delivered paclitaxel-loaded lipid nanocarrier antitumor effect.Development and characterization of a new plasmid delivery system based on chitosan-sodium deoxycholate nanoparticles.Lipid nanoparticles containing oryzalin for the treatment of leishmaniasis.Levofloxacin-loaded bone cement delivery system: highly effective against intracellular bacteria and Staphylococcus aureus biofilms.Microencapsulated Solid Lipid Nanoparticles as a Hybrid Platform for Pulmonary Antibiotic Delivery.Lipid-based nanoformulations of trifluralin analogs in the management of Leishmania infantum infections.Activity of daptomycin- and vancomycin-loaded poly-epsilon-caprolactone microparticles against mature staphylococcal biofilms.Novel doped calcium phosphate-PMMA bone cement composites as levofloxacin delivery systems.Lipid nanoparticles as an emerging platform for cannabinoid delivery: physicochemical optimization and biocompatibility.Incorporation of tocopherol acetate-containing particles in acrylic bone cement.Development of a new delivery system consisting in 'drug-in cyclodextrin-in PLGA nanoparticles'.Polyol additives modulate the in vitro stability and activity of recombinant human phenylalanine hydroxylase.Surface modified polymeric nanoparticles for immunisation against equine strangles.Streptococcus equi antigens adsorbed onto surface modified poly-epsilon-caprolactone microspheres induce humoral and cellular specific immune responses.Cross-linked alginate-gelatine beads: a new matrix for controlled release of pindolol.The enhancement of the immune response against S. equi antigens through the intranasal administration of poly-epsilon-caprolactone-based nanoparticles.A QRM Discussion of Microbial Contamination of Non-Sterile Drug Products, using FDA's and EMA's Warning-Letters between 2008 and 2016.The size of solid lipid nanoparticles: an interpretation from experimental design.Nystatin and lidocaine pastilles for the local treatment of oral mucositis.Annealing as a tool for the optimization of lyophilization and ensuring of the stability of protein-loaded PLGA nanoparticles.Lymphatic uptake of pulmonary delivered radiolabelled solid lipid nanoparticles.Chitosan Nanoparticles as a Mucoadhesive Drug Delivery System for Ocular Administration.A biomolecular recognition approach for the functionalization of cellulose with gold nanoparticles.
P50
Q30378025-CE4323B1-B348-430F-AAEC-07BFDB876AC3Q30824419-E56D6EE2-3D49-42FC-9E3D-58C874FAF45BQ34316799-C703BE10-4D0F-42F8-BCB5-817FC56CAEB3Q36941463-F474691C-B3EF-44EF-92E2-6317519F99D6Q38094761-FA9F12E9-CD60-431D-94E2-5701231446A7Q38593688-080CA684-A9E3-41EE-B38A-68C61C639A8BQ38601755-916B6F4C-2858-4087-8C4C-B41F18BD39BCQ38702876-E20B25C8-F290-4779-9581-5DE10776734BQ38784097-A95ACEA5-DC4F-40C7-A1EE-94860886EBBAQ38790254-61D15CEA-9C7B-47B8-9D16-71F09822BB72Q38812490-45D878EE-CB40-4334-9115-ED39A122E0DAQ38816059-1234C5D0-65FA-45B2-8909-44E02EF45633Q38879711-9CCF4132-C6FE-43E4-B976-FC590A4AA95BQ38896691-AC653866-24A7-464B-9A3D-490E2D6023C5Q38899817-90A1D072-13C6-4F2C-B688-1A32CA6D4944Q39013151-2B6C69B8-FC18-4778-9DB1-B8B2E9CB1C1DQ39186500-A94188CE-772D-457B-80FB-3EE4F64145ADQ39420800-20234F79-B9A0-4F53-8E9D-4897BB67139FQ39460556-E118C34C-5B51-4157-A20F-78EF75743F92Q39461121-0AB5622A-0786-42F9-BD8F-8BB6622C66EFQ40075830-51885D9D-C3D4-421B-A762-F5D39CBD448FQ40092850-2E86801E-A470-45AE-9993-61B39AB01758Q40877550-210AC561-4328-43A7-8248-703009FC024AQ41103271-0C04975F-8619-4C8A-B362-7320B7FCDEC3Q41206337-A4B7802A-A598-4B13-A554-4769E7F14563Q42827034-48C4D834-DC1C-440F-95C8-3894D27873DDQ43066597-0CDEBF16-6627-43E2-82B1-1617F345DBF6Q43180561-53EF2256-8FD8-46ED-89C9-A1D316A6CE42Q43235998-A08CFE2F-8486-40EF-848D-BDC0FB399F62Q43262376-B46ACA46-5DBD-4469-B386-61B1DCFE6462Q44630959-F86CDB46-D978-476F-BEFB-22ABE330FD6FQ44948621-785CC7A3-5B3D-4A58-94A9-9E9CF5C28245Q46232686-71737D24-CAAF-4A05-ADBA-5CA894D45C20Q47307161-FFBC01E5-E566-4E44-A8DB-C9CEF312C5A1Q47395831-6626E3C1-9775-4A9D-94E3-5420A9E6277DQ47400944-07107EC4-A6B5-4164-A23F-B2B6326CF1E3Q47880521-5785DA5B-547A-4601-8269-F52CE233B641Q47989300-9DB76EFD-95BA-49FC-B6DF-8D8505B11C51Q48198477-FB4DC01F-85C4-4E73-9A8D-7F509CB5BF9BQ48267277-52E93151-813D-427E-87D8-05A09FB68DBE
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
A J Almeida
@es
A J Almeida
@nl
A J Almeida
@sl
A J. Almeida
@en
type
label
A J Almeida
@es
A J Almeida
@nl
A J Almeida
@sl
A J. Almeida
@en
prefLabel
A J Almeida
@es
A J Almeida
@nl
A J Almeida
@sl
A J. Almeida
@en
P1053
I-6590-2012
P106
P1153
7202913772
P31
P3829
P496
0000-0002-7807-4726